---
$id: https://graph.org.ai/products/commodity/51182019
$type: Product
source: UNSPSC
code: "51182019"
title: "Androstenedione"
class: "51182000"
classTitle: "Androgens and androgen inhibitors"
family: "51180000"
familyTitle: "Hormones and hormone antagonists"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Androstenedione

**UNSPSC Code**: 51182019
**Class**: [Androgens and androgen inhibitors](Androgens and androgen inhibitors.mdx)
**Family**: [Hormones and hormone antagonists](../Hormones and hormone antagonists.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an anabolic steroid with the molecular formula C19H26O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 409J2J96VR, chemically known as 3,17-dioxoandrost-4-ene but generally known as androstenedione, which bears US NIH Compound Identifier 6128. European Medicines Agency schedules Androstenedione in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB12900MIG. As of Q4 2014, ANDROSTENEDIONE remains the US FDA Preferred Term for this commodity. Androstenedione bears US NLM identifiers UMLS ID CL026907 and NCI Concept Code C2300. SMILES: O=C1C2(C(C3C(C4(C(=CC(=O)CC4)CC3)C)CC2)CC1)C. .

